Incyte Corporation

Total Valuation

Incyte Corporation carries a market capitalization of 19.57B, placing it among publicly traded companies globally. Its enterprise value stands at 14.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Incyte Corporation currently has 199.95M shares outstanding.

Valuation Ratios

Incyte Corporation trades at a trailing price-to-earnings ratio of 12.92. The price-to-sales ratio is 3.45, and the price-to-book ratio stands at 35.77.

Enterprise Valuation

On an enterprise value basis, Incyte Corporation trades at an EV/EBITDA multiple of 9.40 and an EV/FCF ratio of 9.38. The EV/Sales ratio of 2.71 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.02 provides insight into valuation relative to core operating earnings.

Financial Position

Incyte Corporation maintains a current ratio of 3.68, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.70, indicating moderate leverage, while an interest coverage ratio of 661.09 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Incyte Corporation has paid 342.08M in income taxes, reflecting an effective tax rate of 19.28.

Stock Price Statistics

Incyte Corporation's stock has gained approximately 45.99911% over the past 52 weeks. The 50-day moving average sits at 95.94, while the 200-day moving average is 95.78.

Income Statement

Over the trailing twelve months, Incyte Corporation generated 5.36B in revenue and converted that into 1.43B in net income, yielding earnings per share of 7.06. EBITDA reached 1.54B, while operating income came in at 1.45B.

Balance Sheet

Incyte Corporation holds 4.02B in cash and equivalents against 39.43M in total debt, resulting in a net debt position of -3.46B. Total book value stands at 517.30M, with working capital of 3.99B providing operational flexibility.

Cash Flow

Incyte Corporation produced 1.52B in operating cash flow over the past twelve months. After subtracting -30.00M in capital expenditures, free cash flow totaled 1.49B - equivalent to 7.56 per share.

Margins

Incyte Corporation operates with a gross margin of 92.48, reflecting its pricing power and cost economics. The operating margin of 27.05 and net profit margin of 26.71 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Incyte Corporation's most recent stock split took place on September 1, 2000 with a 1:2 split ratio.

Scores

Incyte Corporation posts an Altman Z-Score of 8.68, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.